ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue87,19085,53182,46076,427
Cost of Revenue61,60759,29957,25653,111
Gross Profit25,58326,23225,20423,316
Operating Expenses
Research Development4,5084,7375,9465,603
Selling General and Administrative14,52015,01915,19614,233
Non Recurring----
Others----
Total Operating Expenses80,63579,05578,39872,947
Operating Income or Loss6,5556,4764,0623,480
Income from Continuing Operations
Total Other Income/Expenses Net58-181-482-330
Earnings Before Interest and Taxes6,5556,4764,0623,480
Interest Expense-63-183-215-248
Income Before Tax6,6136,2953,5803,150
Income Tax Expense-18,386-1,36998310
Minority Interest-85-154-170-143
Net Income From Continuing Ops24,9997,6643,4822,840
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income24,9307,6483,5092,869
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares24,9307,6483,5092,869